WHO analysis: Cost of new HCV meds unaffordable globally

The cost of new medicines for patients infected with hepatitis C virus vary widely around the globe, especially when adjusted for national wealth, results from an economic analysis led by World...
Source: Family Practice News - Category: Primary Care Source Type: news